Matthew Shawn Morris sold $341k of PRVA
director at Privia Health Group, Inc.. 13,647 shares at an average of $25.01, traded Dec 12, 2025, filed Dec 16, 2025.
Score components
- +15RoleDirector
- +15Trade size$341k at market
- +5Share of holdings soldSold 17% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +0.2%, 3m -7.2%, 6m -1.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001401958-25-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 12, 2025 | MOption exercise Common Stock, par value $0.01 per share10b5-1 | +13,647 | $2.00 | $27k | 81,835 | Dec 16, 2025 |
| Dec 12, 2025 | SOpen-market sale Common Stock, par value $0.01 per share10b5-1 | -13,647 | $25.01 | $341k | 68,188 | Dec 16, 2025 |
| Dec 12, 2025 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -13,647 | $0.00 | $0 | 3,716,652 | Dec 16, 2025 |
Related signals
Other insiders at Privia Health Group, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 34Weak | Privia Health Group, Inc. | David Mountcastle EVP & Chief Financial Officer | $589k 21,275 shares | -11% | |
| 10Weak | Privia Health Group, Inc. | David Mountcastle EVP & Chief Financial Officer | $17k 600 shares | -0% | |
| 33Weak | Privia Health Group, Inc. | Matthew Shawn Morris director | $3.1M 112,759 shares | -83% | |
| 36Weak | Privia Health Group, Inc. | David Mountcastle EVP & Chief Financial Officer | $680k 24,734 shares | -12% | |
| 33Weak | Privia Health Group, Inc. | Matthew Shawn Morris director | $3.6M 135,498 shares | -105% | |
| 33Weak | Privia Health Group, Inc. | Matthew Shawn Morris director | $3.8M 151,322 shares | -92% | |
| 12Weak | Privia Health Group, Inc. | David Mountcastle EVP & Chief Financial Officer | $433k 17,196 shares | -8% | |
| 50Moderate | Privia Health Group, Inc. | Parth Mehrotra Chief Executive Officer | $2.7M 121,086 shares | -22% | |
| 45Moderate | Privia Health Group, Inc. | David Mountcastle EVP & Chief Financial Officer | $77k 3,385 shares | -2% | |
| 17Weak | Privia Health Group, Inc. | Matthew Shawn Morris director | $453k 18,113 shares | -21% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.